Agios Pharmaceuticals (AGIO) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Agios Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$54.03M

Latest Revenue (Q)

$12.88M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

Agios Pharmaceuticals Revenue by Period

Agios Pharmaceuticals Revenue by Year

Date	Revenue	Change
2025-12-31	$54.03M	48.03%
2024-12-31	$36.50M	36.07%
2023-12-31	$26.82M	88.36%
2022-12-31	$14.24M	100.00%
2021-12-31	-	100.00%
2020-12-31	-	-100.00%
2019-12-31	$117.91M	24.92%
2018-12-31	$94.39M	119.45%
2017-12-31	$43.01M	-38.46%
2016-12-31	$69.89M	18.22%
2015-12-31	$59.12M	-9.55%
2014-12-31	$65.36M	155.82%
2013-12-31	$25.55M	1.76%
2012-12-31	$25.11M	14.97%
2011-12-31	$21.84M	-

Agios Pharmaceuticals generated $54.03M in revenue during NA 2025, up 48.03% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Agios Pharmaceuticals Revenue by Quarter

Date	Revenue	Change
2025-09-30	$12.88M	3.41%
2025-06-30	$12.46M	42.73%
2025-03-31	$8.73M	-18.68%
2024-12-31	$10.73M	19.70%
2024-09-30	$8.96M	4.05%
2024-06-30	$8.62M	5.20%
2024-03-31	$8.19M	15.29%
2023-12-31	$7.10M	-4.00%
2023-09-30	$7.40M	10.24%
2023-06-30	$6.71M	19.66%
2023-03-31	$5.61M	30.14%
2022-12-31	$4.31M	22.58%
2022-09-30	$3.52M	-37.01%
2022-06-30	$5.58M	570.91%
2022-03-31	$832.00K	100.00%
2021-12-31	-	100.00%
2021-09-30	-	-100.00%
2021-06-30	$37.35M	-9.81%
2021-03-31	$41.41M	-5.98%
2020-12-31	$44.05M	26.91%
2020-09-30	$34.71M	-7.07%
2020-06-30	$37.35M	-57.12%
2020-03-31	$87.10M	145.76%
2019-12-31	$35.44M	36.18%
2019-09-30	$26.02M	-0.75%
2019-06-30	$26.22M	-13.25%
2019-03-31	$30.23M	0.71%
2018-12-31	$30.01M	97.48%
2018-09-30	$15.20M	-62.39%
2018-06-30	$40.41M	361.24%
2018-03-31	$8.76M	-10.58%
2017-12-31	$9.80M	-13.73%
2017-09-30	$11.36M	0.11%
2017-06-30	$11.35M	7.97%
2017-03-31	$10.51M	-53.60%
2016-12-31	$22.65M	152.06%
2016-09-30	$8.98M	28.76%
2016-06-30	$6.98M	-77.69%
2016-03-31	$31.28M	403.07%
2015-12-31	$6.22M	13.47%
2015-09-30	$5.48M	-58.54%
2015-06-30	$13.22M	-61.35%
2015-03-31	$34.20M	133.68%
2014-12-31	$14.64M	-56.83%
2014-09-30	$33.90M	303.04%
2014-06-30	$8.41M	-
2014-03-31	$8.41M	24.72%
2013-12-31	$6.74M	7.59%
2013-09-30	$6.27M	-
2013-06-30	$6.27M	-
2013-03-31	$6.27M	-0.22%
2012-12-31	$6.28M	0.22%
2012-09-30	$6.27M	-0.32%
2012-06-30	$6.29M	0.32%
2012-03-31	$6.27M	-

Agios Pharmaceuticals generated $12.88M in revenue during Q3 2025, up 3.41% compared to the previous quarter, and up 149.51% compared to the same period a year ago.

Agios Pharmaceuticals Revenue Breakdown

Agios Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 20
Product	$54.03M	$36.50M	$26.82M	$11.74M	$121.09M
Royalty	-	-	-	$2.50M	$10.26M
Committee Participation	-	-	-	-	-
Collaboration Revenue, Related Party	-	-	-	-	$68.27M
Research Services	-	-	-	-	$64.35M
Development Activities	-	-	-	-	-
Commercialization Activity	-	-	-	-	$3.93M

Agios Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (100.00%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 20	Sep 20	Jun 20	Mar 20
Product	$19.97M	$12.88M	$12.46M	$8.73M	$10.73M	$8.96M	$8.62M	$8.19M	$7.10M	$7.40M	$6.71M	$5.61M	$4.31M	$3.52M	$3.08M	$832.00K	$39.12M	$31.72M	$27.58M	$22.67M
Royalty	-	-	-	-	-	-	-	-	-	-	-	$2.91M	$683.00K	$3.34M	$3.33M	-	-	-	-	-
Collaboration Revenue, Related Party	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$2.50M	$1.24M	$1.21M	$5.74M	$60.10M	-
Commercialization Activity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.02M	-	-	-
Research Services	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$214.00K	-	-	-

Agios Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Product (100.00%).

Agios Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25
Non-US	$4.86M
UNITED STATES	$49.17M

Agios Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (91.01%), and Non-US (8.99%).

Agios Pharmaceuticals Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
SRPT	Sarepta Therapeutics	$2.20B	$399.36M
RCUS	Arcus Biosciences	$247.00M	$26.00M
GLPG	Galapagos	$239.70M	$62.43M
LQDA	Liquidia	$158.32M	$54.34M
IBRX	ImmunityBio	$113.29M	$32.06M
RXRX	Recursion Pharmaceuticals	$74.68M	$5.17M
AGIO	Agios Pharmaceuticals	$54.03M	$12.88M
COGT	Cogent Biosciences	-	-
BEAM	Beam Therapeutics	-	-
DNLI	Denali Therapeutics	-	-

AGIO Revenue FAQ

What is Agios Pharmaceuticals’s yearly revenue?

Agios Pharmaceuticals's yearly revenue for 2025 was $54.03M, representing an increase of 48.03% compared to 2024. The company's yearly revenue for 2024 was $36.5M, representing an increase of 36.07% compared to 2023. AGIO's yearly revenue for 2023 was $26.82M, representing an increase of 88.36% compared to 2022.

What is Agios Pharmaceuticals’s quarterly revenue?

Agios Pharmaceuticals's quarterly revenue for Q3 2025 was $12.88M, a 3.41% increase from the previous quarter (Q2 2025), and a 43.69% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $12.46M, a 42.73% increase from the previous quarter (Q1 2025), and a 44.57% increase year-over-year (Q2 2024). AGIO's quarterly revenue for Q1 2025 was $8.73M, a -18.68% decrease from the previous quarter (Q4 2024), and a 6.56% increase year-over-year (Q1 2024).

What is Agios Pharmaceuticals’s revenue growth rate?

Agios Pharmaceuticals's revenue growth rate for the last 3 years (2023-2025) was 101.42%, and for the last 5 years (2021-2025) was 0%.

What are Agios Pharmaceuticals’s revenue streams?

Agios Pharmaceuticals's revenue streams in c 25 are Product

What is Agios Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Agios Pharmaceuticals was Product. This segment made a revenue of $54.03M, representing 100.00% of the company's total revenue.